Omeprazole Market: Introduction
- Omeprazole, a drug belonging to proton pump inhibitors (PPIs) class, is used to decrease the amount of acid produced in the stomach. It was discovered in 1979 and appears on the World Health Organizations’ List of Essential Medicines. According to the NHS Business Services Authority (NHSBSA) statistics, over 2 million items of omeprazole were prescribed in the U.K. in March 2018 alone. It is one of the most widely prescribed medications across the globe. According to drug usage statistics published by ClinCalc, the number of omeprazole prescription in the U. S. increased from 26 million to 70 million from 2006 to 2019.
Request For Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56199
- Omeprazole is utilized alone or prescribed in combination with other medications. It is used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions caused due to excessive stomach acid. Frequent flow of stomach acid into the esophagus, which irritates the lining of esophagus, can cause GERD. Omeprazole is employed with other medications in the treatment of infections caused by H. pylori bacteria.
Key Drivers, Restraints, and Opportunities of Global Omeprazole Market
- Rising cases of duodenal ulcers is anticipated to fuel the omeprazole market. As per the survey by Virtual Medical Centre, 2016, peptic ulcer is a highly common disease, occurring in about 10% to 15% of the global population at a time. It is common in geriatric patients. The survey also stated that duodenal ulcers are four times more common than gastric ulcers. Furthermore, rising awareness activities for the treatment of gastrointestinal disorders by various organizations is a major factor propelling the market. For instance, the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a non-profit education and research organization supports to improve the life of people affected by chronic digestive conditions. IFFGD improves awareness and supports research for the treatment of gastrointestinal disorders and educate individuals. Positive outcomes of omeprazole in the clinical trials in H.pylori eradication therapy is anticipated to boost the demand for omeprazole during the forecast period. For instance, in December 2018, RedHill Biopharma announced the Phase 3 results of Talicia capsule combining antibiotics and proton pump inhibitor omeprazole for the treatment of Helicobacter pylori infection.
- The common side-effects of omeprazole include stomach pain, flatulence, nausea, vomiting, diarrhea, and headache. Increase in prevalence of peptic and duodenal ulcers and awareness about gastrointestinal disorder in developing countries is expected to propel the omeprazole market during the forecast period. Side-effects associated with omeprazole are likely to hamper the omeprazole market during the forecast period.
Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=56199
North America to Capture Major Share of Global Omeprazole Market
Based on region, the global omeprazole market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2020 due to the increase in incidences of H.pylori infection, which causes ulcers. Peptic ulcer disease (PUD) affects approximately 4.5 million people in the U.S. annually. Approximately 10% of the U.S. population suffers from duodenal ulcer. The market in Asia Pacific is anticipated to expand at a substantial CAGR owing to a rise in prevalence of H.pylori infection in the region.
Furthermore, attractive discount programs offered by various online portals to delivers a cost-effective option for the prescription product is anticipated to propel the market. For instance, SingleCare, an online service for prescriptions, partners with major pharmacies in the U.S. and assists patients to save around 80% on prescription cost, thereby providing access to affordable treatment. Additionally, generic omeprazole is covered by most Medicare and insurance plans.
Pre Book A Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=56199<ype=S
Key Players Operating in Global Omeprazole Market
The global omeprazole market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global omeprazole market are:
- Astrazeneca Plc.
- Sandoz, Inc.
- Mylan N.V.
- Apotex, Inc.
- Dr. Reddy’s Laboratories, Inc.
- Impax Laboratories, Inc.
- Perrigo Company Plc
- Santarus, Inc.
- Watson laboratories, Inc.
- Lek Pharmaceuticals d.d.
- Aurobindo Pharma Limited
- Amneal Pharmaceuticals LLC,
- Salix Pharmaceuticals
- Spansules Pharma
- Systacare Remedies
- Sainor Laboratories
- Allergan plc.
- Others
More Trending Reports by Transparency Market Research
- Vascular Access Devices Market: https://www.prnewswire.co.uk/news-releases/global-vascular-access-devices-market-to-grow-with-advancements-in-cardiovascular-treatment-lines-says-tmr-823600417.html
- Tissue Processing Systems Market: https://www.prnewswire.com/news-releases/wide-range-of-applications-bringing-growth-opportunities-for-tissue-processing-systems-market-tmr-301209993.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Global Rare Neurological Disease Treatment Market – OverviewRare neurological diseases are vastly underdiagnosed and most of them go untreated.
It is expected that the global rare neurological disease treatment market will have a great potential in the coming years of the forecast period ranging from 2020 to 2030.
Increasing awareness about these diseases, advancing healthcare and neurobiological technologies, and fast track approvals of new treatment methods are some of the key factors that will help in pushing up the growth of the global market.Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=79898Global Rare Neurological Disease Treatment Market – Notable DevelopmentsIn terms of competitive landscape of the global neurological disease treatment market, there are several key players operating in the market space.
This makes the competitive landscape a highly fragmented one.
The companies in the market are mainly focusing on developing new and innovative therapeutics to diagnose and treat these neurological diseases.The market consists of a few significant players who dominate the market.
Some of the leading market players include CSL Ltd, Kedrion Biopharma Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Merz Pharma GmbH & Co. KGaA, Aquestive Therapeutics Inc., Bayer AG, Pfizer Inc., Novartis AG, Merck & Co. Inc. (EMD Serono Inc.), and Jazz Pharmaceuticals PLC.Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=79898Global Rare Neurological Disease Treatment Market – Driver and RestraintsThere are several factors that are responsible for the overall development of the global rare neurological disease treatment market.
The EB-5 is also known as the employment-based 5th preference category, which was produced to attract foreign capital to create job opportunities and enhance the US economy.
While no one mandates that you hire an EB-5 program attorney, but it is undoubtedly advisable.
When you are committing to an EB-5 project with the hope of receiving a green card for yourself, spouse and the unmarried minor kids, but if you try to save money in this way, it hardly makes any sense.Hire an Expert!While you could hire a lawyer who is not an expert in the EB-5 visas for the task, it may prove to be unwise.
Will you go to a doctor who is not a specialist in the domain?
They later got the visa after hiring an attorney.
The result is that DIY wasted a lot of time and also money as they did not have the legal help.
Custom Feather Flags are the most common style of flags purchased by businesses for outdoor advertising.order now get big discounts on branded canopy tents.
Contact Us Branded Canopy Tents San Francisco Office 1390 Market Street,Suite 200 San Francisco 94102 USA [email protected] Website:-https://www.brandedcanopytents.com/ Google Map URL: https://bit.ly/3gu2Bz9
